52

Gujarat Terce Laboratories LtdBOM 524314 Stock Report

Last reporting period 30 Sep, 2023

Updated 20 Sep, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XBOM - Bombay Stock Exchange

524314.BO Stock Analysis

52

Uncovered

Gujarat Terce Laboratories Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.002

Dividend yield

Shares outstanding

7.42 B

Gujarat Terce Laboratories Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its diverse portfolio encompasses approximately 70 brands and 180 stock-keeping units (SKUs) covering multiple dosage forms, such as tablets, capsules, oral liquids, ointments and injectables. The firm offers therapies in areas of antibiotics, gynecology, respiratory, nutraceuticals, gastrointestinal and anti-fungal. The Company’s brands include Acolate, Codimol, Resplash, Terflora Z, Thyter, Tynol, Z-Oxi and Vitfol. The firm has approximately eight brands occupying a space in the top 10 in various therapeutic areas. The firm has a presence in over 13 states in India. The firm also has a presence in Eastern and Western Africa, the association of Southeast Asian Nations (ASEAN), and Latin American (LATAM) countries.

View Section: Eyestock Rating